Literature DB >> 28670697

Estimation of glomerular filtration rate using serum cystatin C and creatinine in adults with sickle cell anemia.

Marianne E M Yee1,2, Peter A Lane1,2, David R Archer1,2, Clinton H Joiner1,2, James R Eckman3, Antonio Guasch4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28670697     DOI： 10.1002/ajh.24840

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  11 in total

1.  Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.

Authors:  Rima S Zahr; Marianne E Yee; Jack Weaver; Katherine Twombley; Raed Bou Matar; Diego Aviles; Rajasree Sreedharan; Michelle N Rheault; Rossana Malatesta-Muncher; Hillarey Stone; Tarak Srivastava; Gaurav Kapur; Poornima Baddi; Oded Volovelsky; Jonathan Pelletier; Rasheed Gbadegesin; Wacharee Seeherunvong; Hiren P Patel; Larry A Greenbaum
Journal:  Pediatr Nephrol       Date:  2019-04-03       Impact factor: 3.714

2.  Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.

Authors:  Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Maureen M Achebe; Nwamaka D Eneanya; Ravi I Thadhani; Sagar U Nigwekar; Sahir Kalim
Journal:  J Am Soc Nephrol       Date:  2019-12-06       Impact factor: 10.121

3.  Cystatin C as a biomarker of chronic kidney disease: latest developments.

Authors:  Stefanie W Benoit; Eileen A Ciccia; Prasad Devarajan
Journal:  Expert Rev Mol Diagn       Date:  2020-05-25       Impact factor: 5.225

4.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

5.  Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.

Authors:  Vimal K Derebail; Qingning Zhou; Emily J Ciccone; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2021-08-16       Impact factor: 8.615

Review 6.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

7.  Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.

Authors:  Jeffrey D Lebensburger; Inmaculada Aban; Brandi Pernell; Malgorzata Kasztan; Daniel I Feig; Lee M Hilliard; David J Askenazi
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

8.  Acute Kidney Injury among Black Patients with Sickle Cell Trait and Sickle Cell Disease.

Authors:  Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Sagar U Nigwekar; Sahir Kalim
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-08       Impact factor: 8.237

9.  Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.

Authors:  Vimal K Derebail; Emily J Ciccone; Qingning Zhou; R Rosina Kilgore; Jianwen Cai; Kenneth I Ataga
Journal:  Am J Kidney Dis       Date:  2019-02-21       Impact factor: 11.072

10.  Investigations of Kidney Dysfunction-Related Gene Variants in Sickle Cell Disease Patients in Cameroon (Sub-Saharan Africa).

Authors:  Valentina J Ngo-Bitoungui; Suzanne Belinga; Khuthala Mnika; Tshepiso Masekoameng; Victoria Nembaware; René G Essomba; Francoise Ngo-Sack; Gordon Awandare; Gaston K Mazandu; Ambroise Wonkam
Journal:  Front Genet       Date:  2021-03-15       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.